Outcomes & Research

The GLP-1 research we build from.

Verified facts about how the practice operates today, alongside the peer-reviewed trial data behind widely prescribed GLP-1 medications. Full methodology and citations, so you can check every source yourself.

Precision Nutrition. Most Plans Covered.
Verified practice facts
01
Coverage

Most plans cover dietitian visits.

We verify your benefits with your carrier and tell you what you will owe before anything is booked.

02
Network

In network with most major insurance plans.

Coverage varies by state and plan, so we verify yours first.

03
Timing

Coverage confirmed within one business day.

Visits typically within a few business days.

Published Research

The published benchmarks.

Average weight reductions reported in the landmark trials for the widely prescribed GLP-1 medications. These are results from the trial populations described below, not Full Precision Health patient outcomes, and every figure links to its source.

SemaglutideSTEP-1
14.9%

Average body weight reduction at week 68 in the medication group. Both the medication and placebo groups received lifestyle counseling.

Dose

2.4 mg weekly (titrated over 16 weeks)

Duration

68 weeks

Population

1,961 adults with BMI ≥ 30 (or ≥ 27 with comorbidity) without diabetes. Trial included lifestyle intervention for both medication and placebo groups.

TirzepatideSURMOUNT-1
20.9%

Average body weight reduction at week 72 in the medication group. Both the medication and placebo groups received lifestyle counseling.

Dose

15 mg weekly (titrated)

Duration

72 weeks

Population

2,539 adults with BMI ≥ 30 (or ≥ 27 with weight-related complication) without diabetes. Trial included lifestyle intervention for both medication and placebo groups.

Important Limitations

What this data does not say.

These benchmarks do not represent outcomes of Full Precision Health patients. We have not published outcomes data. Individual results depend on your health, dose, adherence, and many clinical factors.

Trial participants followed a structured protocol with lifestyle intervention (nutrition counseling and physical activity guidance) alongside the medication. Both the medication and placebo groups received lifestyle counseling. These two trials did not test dietitian visits or show what adding dietitian care would change. They enrolled different populations and are not a head-to-head comparison.

These medications carry side effect profiles, contraindications, and require medical supervision. Not every patient is a candidate for GLP-1 therapy, and your clinician will help you understand whether it's appropriate for your specific situation.

Full Precision Health provides dietitian care and (where appropriate) coordinates with your prescriber. We do not promise specific outcomes, and nutrition care never requires medication.

Individual results vary. These are trial averages, not FPH outcomes.

The figures above are the average weight-reduction results reported in large, peer-reviewed clinical trials. They reflect the trial populations, doses, and durations described, not the outcomes of Full Precision Health patients specifically. Your results will depend on your medical history, adherence, dose, lifestyle, and clinical response. Full Precision Health does not guarantee these outcomes. Speak with your clinician about what's realistic for you.

Questions about nutrition care alongside a GLP-1?

Book a visit with a registered dietitian. We will review your history and goals and build a nutrition plan that fits. Medication decisions stay with your own prescriber.

Check My Coverage